S

Smith & Nephew plc

D
SNN
USD
0.255
(1.0419%)
Market Closed
26,592.00
Volume
1.9676
EPS
2.41
Div Yield
35.430
P/E
10,781,943,029.02
Market Cap
Today
1.0419%
1 Week
-1.435%
1 Month
-14.132%
6 Months
-0.822%
12 Months
2.465%
Year To Date
-9.414%
All Time
0%
News

Treasury Yields Decline as Market Anticipates Fed Rate Cuts

26.08.2024
Economy news

Novo Nordisk Surges in Profit and Sales

02.05.2024
Stocks news
More
Related Instruments
NVS
NVS
0.23
(0.2153%)
USD
GSK
GSK
0.89
(2.4881%)
USD
PFE
PFE
0.105
(0.3839%)
USD
ABBV
ABBV
-0.78
(-0.3876%)
USD
LLY
LLY
21.245
(2.7359%)
USD
MRK
MRK
0.46
(0.4567%)
USD
AMGN
AMGN
-2.74
(-0.8439%)
USD
BMY
BMY
-0.57
(-1.0313%)
USD
JNJ
JNJ
-1.03
(-0.6528%)
USD
GILD
GILD
6.23
(6.7946%)
USD

Title:
Smith & Nephew plc

Sector:
Healthcare
Industry:
Medical Devices
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 41% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Do you need help or have a question?
Contact Us